ES2336758B1 - PSEUDOMONAS FLUORESCENS N. 21.4 STIMULANT OF THE SECONDARY METABOLISM OF PHENOLIC COMPOUNDS. - Google Patents

PSEUDOMONAS FLUORESCENS N. 21.4 STIMULANT OF THE SECONDARY METABOLISM OF PHENOLIC COMPOUNDS. Download PDF

Info

Publication number
ES2336758B1
ES2336758B1 ES200902176A ES200902176A ES2336758B1 ES 2336758 B1 ES2336758 B1 ES 2336758B1 ES 200902176 A ES200902176 A ES 200902176A ES 200902176 A ES200902176 A ES 200902176A ES 2336758 B1 ES2336758 B1 ES 2336758B1
Authority
ES
Spain
Prior art keywords
pseudomonas fluorescens
cect
phenolic compounds
application
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200902176A
Other languages
Spanish (es)
Other versions
ES2336758A1 (en
Inventor
Beatriz Ramos Solano
Elena Algar Parejo
Fco.Javier Gutierrez Mañero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacion Universitaria San Pablo CEU
Original Assignee
Fundacion Universitaria San Pablo CEU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion Universitaria San Pablo CEU filed Critical Fundacion Universitaria San Pablo CEU
Priority to ES200902176A priority Critical patent/ES2336758B1/en
Publication of ES2336758A1 publication Critical patent/ES2336758A1/en
Application granted granted Critical
Publication of ES2336758B1 publication Critical patent/ES2336758B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • C12R1/39
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38Pseudomonas
    • C12R2001/39Pseudomonas fluorescens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Pseudomonas fluorescens N21.4 estimulante del metabolismo secundario de compuestos fenólicos. Pseudomonas fluorescens N21.4 stimulating the secondary metabolism of phenolic compounds.

Cepa bacteriana Pseudomonas fluorescens N21.4, microorganismo del grupo de las bacterias Gram-, género
Pseudomonas, estimulante del metabolismo secundario de compuestos fenólicos. Esta cepa ha sido aislada a partir de la rizosfera de Nicotiana glauca, en agar nutritivo (PCA), y ha sido caracterizada desde el punto de vista morfológico, bioquímico y genético mediante secuenciación parcial del gen 16s. Puedo ser utilizada con objeto de incrementar el contenido en compuestos fenólicos en especies vegetales de interés farmacológico y alimentario, cuya aplicación sería obtener mayor cantidad de principios activos y/o nuevos alimentos con un contenido estandarizado en fenoles, como brotes de soja con mayor contenido en isoflavonas, o frutos del bosque con mayor contenido en antocianos, teniendo también aplicación como fitosanitario, fortaleciendo a las plantas frente al ataque de agentes biológicos patógenos.
Bacterial strain Pseudomonas fluorescens N21.4, microorganism of the Gram- group of bacteria, genus
Pseudomonas, stimulant of the secondary metabolism of phenolic compounds. This strain has been isolated from the rhizosphere of Nicotiana glauca, in nutritive agar (PCA), and has been characterized from the morphological, biochemical and genetic point of view by partial sequencing of the 16s gene. I can be used in order to increase the content of phenolic compounds in plant species of pharmacological and food interest, whose application would be to obtain more active ingredients and / or new foods with a standardized content of phenols, such as bean sprouts with higher content in isoflavones, or fruits of the forest with higher anthocyanin content, also having application as a phytosanitary, strengthening plants against the attack of pathogenic biological agents.

Description

Pseudomonas fluorescens N21.4 estimulante del metabolismo secundario de compuestos fenólicos. Pseudomonas fluorescens N21.4 stimulating the secondary metabolism of phenolic compounds.

La presente invención se refiere a una cepa de Pseudomonas fluorescens (N21.4, código interno del laboratorio) para su uso en el tratamiento de plantas con el objeto de inducir la síntesis de compuestos fenólicos. del metabolismo secundario con interés farmacológico y nutricional, además de fortalecer a las plantas frente a los agentes externos, por lo que también resulta de interés como fitosanitario.The present invention relates to a strain of Pseudomonas fluorescens (N21.4, internal laboratory code) for use in the treatment of plants in order to induce the synthesis of phenolic compounds. of secondary metabolism with pharmacological and nutritional interest, in addition to strengthening plants against external agents, so it is also of interest as a phytosanitary.

Esta cepa ha sido depositada con fines de patente en la Colección Española de Cultivos Tipo (CECT), con fecha 29 de octubre de 2009, donde se le ha asignado el número 7620. La CECT tiene su sede en el edificio de investigación de la Universidad de Valencia, sito en el campus de Burjassot (DP 46100 - Valencia, España).This strain has been deposited for the purpose of patent in the Spanish Type Culture Collection (CECT), dated October 29, 2009, where it has been assigned the number 7620. The CECT is headquartered in the University research building of Valencia, located on the Burjassot campus (DP 46100 - Valencia, Spain).

La invención se encuadra dentro de los campos de la biotecnología, la farmacología y los nuevos alimentos- Esta cepa bacteriana puede servir de base para la preparación de diferentes tipos de productos estimulantes del metabolismo secundario de plantas. Estos productos mejorarán el contenido en bioactivos de naturaleza fenólica que puedan constituir principios activos de diversos medicamentos, mejorar la calidad de ciertos alimentos y mejorar la defensa de las plantas frente al ataque de agentes biológicos patógenos.The invention falls within the fields of biotechnology, pharmacology and new foods- This strain bacterial can serve as a basis for the preparation of different types of stimulant products of secondary metabolism of plants. These products will improve the bioactive content of phenolic nature that may constitute active ingredients of various medications, improve the quality of certain foods and improve plant defense against agent attack Biological pathogens

Estado de la técnicaState of the art

Los mecanismos de acción de las bacterias promotoras del crecimiento vegetal, se pueden resumir en dos tipos: directos, cuando los metabolitos producidos alteran el metabolismo de la planta (actividad hormonal, estimulación de los mecanismos defensivos..), e indirectos, cuando sintetizan compuestos que facilitan la captación o movilización de nutrientes o evitan el crecimiento de microorganismos patógenos sobre la planta, sin alterar el metabolismo de la planta.The mechanisms of action of bacteria promoters of plant growth, can be summarized in two types: Direct, when the metabolites produced alter the metabolism of the plant (hormonal activity, stimulation of the mechanisms defensive ..), and indirect, when they synthesize compounds that facilitate the uptake or mobilization of nutrients or prevent growth of pathogenic microorganisms on the plant, without alter the metabolism of the plant.

En este caso resulta de interés uno de los mecanismos directos, es decir que alteran el metabolismo de la planta. La planta posee un metabolismo secundario, altamente inducible, relacionado con la defensa de la planta y adaptaciones a situaciones adversas, a las que tiene que hacer frente. Dentro de este metabolismo secundario se encuentra el metabolismo de compuestos fenólicos., que además de estar relacionados con la defensa de la planta, son de interés para la salud humana, tanto cuando se consumen alimentos de origen vegetal que los contienen de forma natural, como los extractos vegetales dedicados a suplementos nutricionales. También son importantes como fuente de principios activos para la obtención de medicamentos.In this case, one of the direct mechanisms, that is to say that they alter the metabolism of the plant. The plant has a secondary metabolism, highly inducible, related to the defense of the plant and adaptations to adverse situations, which you have to face. Within this secondary metabolism is the metabolism of phenolic compounds., which in addition to being related to plant defense, are of interest to human health, both when you consume plant-based foods that contain them from natural form, such as plant extracts dedicated to supplements Nutritional They are also important as a source of principles assets for obtaining medicines.

Pseudomonas fluorescens pertenece al grupo de las bacterias Gram -. El género Pseudomonas es común entre bacterias del suelo, y pueden ser patógenos oportunistas en animales y patógenos de plantas. Siguiendo la taxonomía del Manual Bergeys, edición marzo de 2001, esta bacteria se encuadra dentro del Dominio Bacteria, Phylum Proteobacteria, Clase gamma proteobacteria, Orden Pseudomonadales, Familia Pseudomonaceae. El género Pseudomonas es muy común en el sistema edáfico, y se ha descrito en repetidas ocasiones como bacteria protectora frente a distintas enfermedades de plantas. Algunas bacterias de este grupo producen pigmentos fluorescentes de colores amarillo-verdosos fácilmente solubles en agua. Entre otras funciones, estos pigmentos actúan como sideróforos (moléculas capaces de capturar el hierro del medio para el metabolismo del microorganismo). Además, presentan una gran versatilidad metabólica debido a un gran número de plásmidos que contienen operones inducibles para la síntesis de enzimas específicas que permitan catabolizar los compuestos presentes en el medio. La presencia de Pseudomonas sp. en la rizosfera de distintas plantas afecta de forma beneficiosa a su fisiología indicando que es muy posible su selección por la planta a nivel rizosférico. Los efectos de esta cepa sobre la fisiología de distintas plantas indican que la planta las selecciona en su beneficio. Pseudomonas fluorescens belongs to the group of Gram - bacteria. The genus Pseudomonas is common among soil bacteria, and can be opportunistic pathogens in animals and plant pathogens. Following the taxonomy of the Bergeys Manual, March 2001 edition, this bacterium is framed within the Bacteria Domain, Phylum Proteobacteria, Gamma Proteobacteria Class, Pseudomonadal Order, Pseudomonaceae Family. The genus Pseudomonas is very common in the edaphic system, and has repeatedly been described as a protective bacterium against various plant diseases. Some bacteria in this group produce fluorescent pigments of yellow-green colors easily soluble in water. Among other functions, these pigments act as siderophores (molecules capable of capturing iron from the medium for the metabolism of the microorganism). In addition, they have great metabolic versatility due to a large number of plasmids containing inducible operons for the synthesis of specific enzymes that allow catabolizing the compounds present in the medium. The presence of Pseudomonas sp. in the rhizosphere of different plants it affects beneficially to its physiology indicating that its selection by the plant at the rhizospheric level is very possible. The effects of this strain on the physiology of different plants indicate that the plant selects them for their benefit.

Si bien existen referencias en la literatura científica que citan Pseudomonas fluorescens por su interés como promotora del crecimiento vegetal y protector frente a patógenos, no se ha citado su capacidad para estimular el metabolismo de compuestos fenólicos. con fines terapéuticos, a través de la nutrición humana o como fuente de principios activos para suplementos nutricionales. (Evidence of disease resistance induced by rhizosphere pseudomonad against pseudomonas-syringae pv, phaseolicola Journal of general and applied microbiology Volume: 41 Issue: 4 Pages: 315-325 Published: AUG 1995. Alstrom, s.; Effect of plant growth-promoting rhizobacteria and culture fíltrate of Sclerotium rolfsii on phenolic and salicylic acid contents in chickpea (Cicer arietinum) Singh UP, Sarma BK, Singh DP CURRENT MICROBIOLOGY Volume: 46 Issue: 2 Pages: 131-140 Published: FEB 2003; Differential methods of inoculation of plant growth-promoting rhizobacteria induce synthesis of phenylalanine ammonialyase and phenolic compounds differentially in chickpeabasha SA (Basha, S. A.), Sarma BK (Sarma, B. K.), Singh DP (Singh, D. P.), Annapurna K (Annapurna, K.), Singh UP (Singh, U. P.) FOLIA MICROBIOLOGICA Volume: 51 Issue: 5 Pages: 463-468 Published: 2006).Although there are references in the scientific literature that cite Pseudomonas fluorescens for its interest as a promoter of plant growth and protective against pathogens, its ability to stimulate the metabolism of phenolic compounds has not been cited. for therapeutic purposes, through human nutrition or as a source of active ingredients for nutritional supplements. (Evidence of disease resistance induced by rhizosphere pseudomonad against pseudomonas-syringae pv, phaseolicola Journal of general and applied microbiology Volume: 41 Issue: 4 Pages: 315-325 Published: AUG 1995. Alstrom, s .; Effect of plant growth-promoting rhizobacteria and culture filtrate of Sclerotium rolfsii on phenolic and salicylic acid contents in chickpea (Cicer arietinum) Singh UP, Sarma BK, Singh DP CURRENT MICROBIOLOGY Volume: 46 Issue: 2 Pages: 131-140 Published: FEB 2003; Differential methods of inoculation of plant growth-promoting rhizobacteria induces synthesis of phenylalanine ammonialyase and phenolic compounds differentially in chickpeabasha SA (Basha, SA), Sarma BK (Sarma, BK), Singh DP (Singh, DP), Annapurna K (Annapurna, K.), Singh UP ( Singh, UP) MICROBIOLOGICAL FOLIA Volume: 51 Issue: 5 Pages: 463-468 Published: 2006).

Realizando una búsqueda retrospectiva de patentes a nivel mundial en la base de datos de producción española Invenet (OEPM) y en la internacional Worlwide, a través del sistema Esp@cenet, se confirma dicha conclusión extraída de la consulta de literatura científica: la inexistencia de documentos de patente relativos a la especie bacteriana Pseudomonas fluorescens como inductora del metabolismo secundario de compuestos fenólicos. con interés farmacológico y nutricional, y también como fitosanitario, ya que tampoco se han encontrado patentes donde se reivindique el uso de Pseudomonas fluorescens como estimulante de compuestos fenólicos. en relación con la defensa de la planta.Carrying out a retrospective search of patents worldwide in the Spanish production database Invenet (SPTO) and in the international Worlwide, through the Esp @ cenet system, the conclusion drawn from the scientific literature consultation is confirmed: the absence of Patent documents related to the bacterial species Pseudomonas fluorescens as inducer of the secondary metabolism of phenolic compounds. with pharmacological and nutritional interest, and also as a phytosanitary, since no patents have been found where the use of Pseudomonas fluorescens as a stimulant of phenolic compounds has been claimed. in relation to the defense of the plant.

Tras la referida búsqueda se ha constatado que existen 419 patentes relacionadas con la bacteria Pseudomonas fluorescens publicadas a nivel mundial (siete con efectos en España), de las cuales sólo cuatro (ninguna española) guardan relación con compuestos fenólicos., pero en ninguna de ellas Pseudomonas fluorescens se caracteriza por su capacidad estimulante del metabolismo secundario de compuestos fenólicos. en plantas, que es el objeto de la presente invención.After the aforementioned search, it has been found that there are 419 patents related to the Pseudomonas fluorescens bacteria published worldwide (seven with effects in Spain), of which only four (none Spanish) are related to phenolic compounds., But none of them Pseudomonas fluorescens is characterized by its stimulating capacity of the secondary metabolism of phenolic compounds. in plants, which is the object of the present invention.

En efecto, en las cuatro patentes encontradas para Pseudomonas fluorescens tienen relación con la metabolización de compuestos fenólicos.; a saber: GB2431926A "Charred biological material carrying microbes", KR2003008 6477A "Microbial agent sewage and watewater treatment", EP1537919A2 "Method for microbiologically decontaminating polluted materials resulting from road demolition" y US6406882B1 "Immobilized microbial consortium for the treatment of phenolic waste-water from petroleum refineries". En todas ellas los compuestos fenólicos. tienen la condición de agentes contaminantes, y el microorganismo se utiliza con el fin de descomponerlos en tratamientos de descontaminación de suelos, aguas residuales, deshechos biodegradables, etc., pero no por su capacidad estimulante del metabolismo secundario de compuestos fenólicos. en especies vegetales.Indeed, in the four patents found for Pseudomonas fluorescens they are related to the metabolism of phenolic compounds .; namely: GB2431926A "Charred biological material carrying microbes", KR2003008 6477A "Microbial agent sewage and watewater treatment", EP1537919A2 "Method for microbiologically decontaminating polluted materials resulting from road demolition" and US6406882B1 "Immobilized microbial consortium-for treatment of phenolic waste from petroleum refineries ". In all of them the phenolic compounds. they have the condition of contaminating agents, and the microorganism is used in order to decompose them in decontamination treatments of soils, sewage, biodegradable waste, etc., but not because of their stimulating capacity of the secondary metabolism of phenolic compounds. in plant species.

La invenciónThe invention

El objeto de la invención que aquí se describe y que, a la vista del estado de la técnica anterior, se entiende cumple con las condiciones de novedad y actividad inventiva necesarias para poder ser merecedora del derecho de patente, es el aislamiento y caracterización de la cepa bacteriana Pseudomonas fluorescens N21.4 (CECT 7620), que es un microorganismo del grupo de las bacterias Gram -, género Pseudomonas, con capacidad de inducir la síntesis de compuestos fenólicos. del metabolismo secundario en especies vegetales que, por la naturaleza de tales compuestos, resultan de interés farmacológico y/o nutricional, además de tener aplicación como fitosanitario frente al ataque de agentes biológicos patógenos.The object of the invention described herein and which, in view of the prior art, is understood to comply with the conditions of novelty and inventive activity necessary to be worthy of the patent right, is the isolation and characterization of the Bacterial strain Pseudomonas fluorescens N21.4 (CECT 7620), which is a microorganism of the Gram - bacteria group, genus Pseudomonas, capable of inducing the synthesis of phenolic compounds. of secondary metabolism in plant species that, due to the nature of such compounds, are of pharmacological and / or nutritional interest, in addition to being applied as a phytosanitary against the attack of pathogenic biological agents.

Las características fisiológicas y el análisis genético de esta cepa permiten identificarla inequívocamente, diferenciándola de otras especies del género Pseudomonas.The physiological characteristics and the genetic analysis of this strain allow us to identify it unequivocally, differentiating it from other species of the genus Pseudomonas .

Una vez aislada y caracterizada, se realizaron diversas pruebas para poner de manifiesto actividades bioquímicas indicadoras de su potencial capacidad de inducción de defensa sistémica y promoción del crecimiento vegetal. Estas fueron, producción de auxinas, degradación de 1-aminociclopropano-l-carboxilato, solubilización de fosfato y producción de sideróforos y quitinasas, resultando positiva para la producción de sideróforos y quitinasas y solubilización de fosfato.Once isolated and characterized, they were performed various tests to reveal biochemical activities Indicators of their potential defense induction capacity systemic and promotion of plant growth. These were, auxin production, degradation of 1-aminocyclopropane-l-carboxylate, phosphate solubilization and production of siderophores and chitinases, proving positive for the production of siderophores and chitinases and phosphate solubilization.

Hasta el momento se han realizado experiencias consistentes en la inoculación de suspensiones bacterianas de Pseudomonas fluorescens sobre semillas de tomate, una Solanacea de gran interés agrícola. En estos experimentos se ha detectado una notable disminución de la biomasa de plantas de tomate de 5 semanas. Sin embargo, las plantas tratadas posteriormente con el patógeno Xanthomonas campestris pv tomate resultaron resistir mejor el ataque del patógeno alcanzando un 40% de disminución de la patología.So far there have been consistent experiences in the inoculation of bacterial suspensions of Pseudomonas fluorescens on tomato seeds, a Solanacea of great agricultural interest. In these experiments a notable decrease in the biomass of tomato plants of 5 weeks has been detected. However, the plants subsequently treated with the pathogen Xanthomonas campestris pv tomato were better able to resist the attack of the pathogen reaching a 40% decrease in the pathology.

Asimismo se ha ensayado la inoculación directa de la cepa en planta modelo (Arajbidopsis thaliana) donde ha inducido un efecto de resistencia sistémica frente a infecciones por el patógeno foliar P.syringae DC3000.The direct inoculation of the strain in the model plant ( Arajbidopsis thaliana ) has also been tested, where it has induced an effect of systemic resistance against infections by the foliar pathogen P.syringae DC3000.

Estos dos experimentos realizados en distintas especies vegetales demuestran que la bacteria es capaz de estimular el metabolismo defensivo, y sin embargo, no existe un análisis de los compuestos responsables de dicha respuesta defensiva.These two experiments performed in different plant species show that the bacteria is able to stimulate defensive metabolism, and yet there is no analysis of the compounds responsible for said defensive response.

Por otro lado, se han realizado experimentos de elicitación con Pseudomonas fluorescens N21.4 en plantas de la familia Leguminosae, en particular, en plántulas de soja (Glycine max. Osumi), observándose un incremento en la producción de isoflavonas, que son compuestos tanto de interés farmacológico, al constituir principios activos de diversos medicamentos, como nutricional, al disponerse de alimentos enriquecidos en dicho compuesto fenólico. Cuando se aplica N21.4 en semillas de plantas de soja (Glycine max. Osumi), se consigue modificar el perfil de isoflavonas, con una mayor concentración de agliconas, formas activas tanto para la defensa de la planta como para la salud humana. Estos experimentos se han realizado tanto mediante la inoculación directa de Pseudomonas fluorescens en el material biológico como mediante elicitación con fragmentos de naturaleza polisacárida procedentes de su pared celular. Asimismo se han realizado experimentos de elicitación con los fragmentos de pared celular sobre cultivos celulares de soja. En todos los casos los resultados han sido semejantes.On the other hand, elicitation experiments have been carried out with Pseudomonas fluorescens N21.4 in plants of the Leguminosae family, in particular in soybean seedlings ( Glycine max. Osumi), observing an increase in the production of isoflavones, which are both of pharmacological interest, by constituting active ingredients of various medications, such as nutritional, by having foods enriched in said phenolic compound. When N21.4 is applied to soybean plant seeds ( Glycine max. Osumi), it is possible to modify the isoflavone profile, with a higher concentration of aglycones, active forms both for the defense of the plant and for human health. These experiments have been carried out both by direct inoculation of Pseudomonas fluorescens in the biological material and by elicitation with fragments of a polysaccharide nature from its cell wall. Elicitation experiments have also been carried out with cell wall fragments on soybean cell cultures. In all cases the results have been similar.

Se han realizado asimismo experimentos de elicitación con Pseudomonas fluorescens N21.4 en plántulas de Hypericum perforatum, familia Hypericaceae, dando como resultado un incremento del contenido de compuestos fenólicos de interés farmacológico. En concreto, su aplicación en plántulas de Hypericum perforatum supone un incremento del contenido en hipericina y pseudohipericina. Estos experimentos se han realizado mediante la inoculación directa de Pseudomonas fluorescens en el material biológico aplicando varias dosis durante 14 semanas.Elicitation experiments have also been carried out with Pseudomonas fluorescens N21.4 in seedlings of Hypericum perforatum , family Hypericaceae, resulting in an increase in the content of phenolic compounds of pharmacological interest. Specifically, its application in Hypericum perforatum seedlings means an increase in the content of hypericin and pseudohypericine. These experiments have been performed by direct inoculation of Pseudomonas fluorescens in the biological material by applying several doses for 14 weeks.

Pseudomonas fluorescens N21.4 puede también aplicarse a cualquier especie de plantas de las que constituyen los frutos rojos o frutos del bosque, como fresa, frambuesa, mora, arándano, o mirtillo, con el objeto de incrementar su contenido en compuestos fenólicos de interés farmacológico, nutricional y/o fitosanitario. En particular, se está ensayando la aplicación de la referida cepa bacteriana en mora (Rubus fruticosus). Pseudomonas fluorescens N21.4 can also be applied to any species of plants that constitute red fruits or berries, such as strawberry, raspberry, blackberry, cranberry, or mirtillo, in order to increase their content in phenolic compounds of pharmacological interest , nutritional and / or phytosanitary. In particular, the application of the aforementioned bacterial strain in blackberry ( Rubus fruticosus ) is being tested.

Los referidos experimentos sobre el uso Pseudomonas fluorescens N21.4 como elicitor del metabolismo secundario de compuestos fenólicos se exponen al final de la presente memoria, dentro del apartado forma de realización.The referred experiments on the use of Pseudomonas fluorescens N21.4 as elicitor of the secondary metabolism of phenolic compounds are presented at the end of the present specification, within the section embodiment.

La finalidad que se persigue, en definitiva, con esta invención y que constituye la ventaja técnica aportada con la misma, es disponer de una bacteria que mejore el contenido en metabolitos secundarios de naturaleza fenólica en plantas de interés farmacológico y nutricional, y que a la vez tenga un efecto como fitosanitario, haciendo entrar en contacto por cualquier medio disponible a dicha bacteria o alguna de sus partes con la planta.The purpose that is pursued, in short, with this invention and that constitutes the technical advantage provided with the it is to have a bacterium that improves the content in secondary metabolites of phenolic nature in plants of interest pharmacological and nutritional, and at the same time have an effect such as phytosanitary, making contact by any means available to said bacterium or any of its parts with the plant.

En consecuencia, con la presente solicitud de patente se reivindica el uso de la cepa Pseudomonas fluorescens N21.4, o cualquier fracción de la misma, para su aplicación en cualquier tipo de especie vegetal, formando parte de cualquier preparado, ya sea individualmente o en combinación con otros organismos, con el fin de incrementar los niveles de metabolitos secundarios de naturaleza fenólica que: 1) mejoren la calidad del producto natural, bien para consumo directo o para la preparación de suplementos nutricionales o de extractos vegetales; 2) sirvan como principios activos para la preparación de diversos medicamentos; y 3) refuercen en cualquier caso la resistencia de las plantas frente a los agentes patógenos externos.Consequently, with the present patent application the use of the strain Pseudomonas fluorescens N21.4, or any fraction thereof, is claimed for application in any type of plant species, forming part of any preparation, either individually or in combination with other organisms, in order to increase the levels of secondary metabolites of phenolic nature that: 1) improve the quality of the natural product, either for direct consumption or for the preparation of nutritional supplements or plant extracts; 2) serve as active ingredients for the preparation of various medications; and 3) reinforce in any case the resistance of plants against external pathogens.

El uso de esta bacteria en plantas, o en cultivos celulares vegetales, permite estimular la síntesis de productos del metabolismo secundario de naturaleza fenólica con interés farmacológico, nutricional y/o fitosanitario.The use of this bacterium in plants, or in plant cell cultures, allows to stimulate the synthesis of secondary metabolic products of phenolic nature with Pharmacological, nutritional and / or phytosanitary interest.

Forma de realizaciónEmbodiment

La cepa del genero Pseudomonas que aquí se reseña se aisló estudiando la rizosfera de poblaciones naturales de Nicotiana glauca en un transecto de la costa mediterránea de Almería. Esta especie vegetal (Nicotiana glauca) se seleccionó por ser de la familia Solanaceae y por tener un metabolismo secundario activo.The strain of the genus Pseudomonas described here was isolated by studying the rhizosphere of natural populations of Nicotiana glauca in a transect of the Mediterranean coast of Almeria. This plant species ( Nicotiana glauca ) was selected for being of the Solanaceae family and for having an active secondary metabolism.

Los muestreos de rizosfera para el aislamiento de la cepa bacteriana se realizaron en poblaciones naturales de Nicotiana glauca en tres suelos distintos en la costa de Almería, en las épocas fría y cálida, durante los años 1999 y 2000. Como resultado de dicho muestreo se coleccionaron 960 cepas entre las que se encontró Pseudomonas fluorescens (N21.4, código interno del laboratorio). El aislamiento de dicha cepa se realizó en agar nutritivo (PCA).The rhizosphere samples for the isolation of the bacterial strain were carried out in natural populations of Nicotiana glauca in three different soils on the coast of Almería, in the cold and warm seasons, during the years 1999 and 2000. As a result of said sampling they were collected 960 strains among which Pseudomonas fluorescens was found (N21.4, internal laboratory code). The isolation of said strain was performed in nutritive agar (PCA).

En el laboratorio este microorganismo se mantiene con una elevada tasa de supervivencia en glicerol al 20% en caldo nutritivo (Pronadisa) a -80ºC o en glicerol al 15% en agua a -20ºC y se recuperan con facilidad en el medio de cultivo utilizado para el aislamiento tanto en fase sólida como en fase líquida a 28ºC.In the laboratory this microorganism is maintains a high 20% glycerol survival rate in nutritive broth (Pronadisa) at -80 ° C or in 15% glycerol in water at -20ºC and recover easily in the culture medium used for insulation in both solid phase and liquid phase a 28 ° C

Para la caracterización de las cepas se consideraron diferentes caracteres fenotípicos que se pormenorizan en esta memoria: (i) morfología de las colonias (ii) morfología de las células, (iii) secuenciación parcial del gen del ADN ribosomal correspondiente a la subunidad 16S.For the characterization of the strains they considered different phenotypic characters that are detailed in this report: (i) colony morphology (ii) morphology of the cells, (iii) partial sequencing of the ribosomal DNA gene corresponding to the 16S subunit.

Características morfológicas, bioquímicas y genéticas de Pseudomonas fluorescens N21.4Morphological, biochemical and genetic characteristics of Pseudomonas fluorescens N21.4

La caracterización taxonómica de Pseudomonas fluorescens se realizó identificando la cepa mediante secuenciación parcial del ADN ribosomal 16S, su comparación con las secuencias existentes en las bases de datos reveló una homología del 98% con una cepa de Pseudomonas fluorescens.Taxonomic characterization of Pseudomonas fluorescens was performed by identifying the strain by partial sequencing of 16S ribosomal DNA, its comparison with the sequences in the databases revealed a 98% homology with a strain of Pseudomonas fluorescens .

A continuación se especifica la morfología de las colonias a las 24 h de incubación a 28º en agar para métodos estándar (PCA).The morphology of colonies at 24 h of incubation at 28º on agar for methods standard (PCA).

       \vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
    

       \vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
    
TABLA 1TABLE 1

1one

Creciendo en medio líquido (Caldo nutritivo Pronadisa) el color del medio cambia a amarillo desde la fase exponencial de crecimiento a la fase estacionaria de crecimiento.Growing in liquid medium (nutritious broth Pronadisa) the color of the medium changes to yellow from the phase exponential growth to the stationary phase of increase.

Los caracteres morfológicos de Pseudomonas fluorescens N21.4 a las 24 h de incubación a 28º en agar para métodos estándar (PCA) corresponden a un bacilo Gram negativo.The morphological characters of Pseudomonas fluorescens N21.4 at 24 h of incubation at 28 ° on agar for standard methods (PCA) correspond to a gram-negative bacillus.

A continuación, se procedió al análisis genético de la cepa para su identificación, para ellos se siguieron los siguientes pasos:Next, we proceeded to the genetic analysis of the strain for identification, for them the Next steps:

Extracción del ADNDNA extraction

Para la extracción del ADN, las colonias crecieron durante 24 horas en caldo nutritivo (Pronadisa) a 28ºC en agitación. Transcurrido este tiempo, Se extrajo el ADN genómico de cada bacteria con el kit Ultraclean™ Microbial DNA isolation (MoBio, CA, EE.UU.), según las indicaciones del fabricante.For DNA extraction, colonies they grew for 24 hours in nutritive broth (Pronadisa) at 28ºC in agitation. After this time, genomic DNA was extracted from each bacterium with the Ultraclean ™ Microbial DNA isolation kit (MoBio, CA, USA), according to the manufacturer's instructions.

Amplificación del ADNr 16S16S rDNA amplification

Se amplificaron mediante PCR los 1500 pb correspondientes a esta región con los siguientes cebadores: directo 5'-AGA GTT TGA TCC TGG CTC AG-3' y reverso 5'-AAG GAG GTG ATC CAG CCG CA-3' (Ulrike, 1989), en una reacción de 25 \muL con 1X de tampón 10X, 2.5 \muM MgCl_{2}, 250 \muM de cada DNTP, 2.5 \muM cebador forward, 2.5 \muM cebador reverse 1,25 unidades de ADN polimerasa (AmpliTaq Applied) y 100 ng del ADN bacteriano. La amplificación se realizó en un termociclador GeneAmp 2700 (Applied Biosystems) con las siguientes condiciones: 95ºC 5 minutos, seguido de 25 ciclos de 94ºC 30 segundos, 65,5ºC 30 segundos y 72ºC 30 segundos, finalizando con 7 minutos a 72ºC.1500 bp were amplified by PCR corresponding to this region with the following primers: direct 5'-AGA GTT TGA TCC TGG CTC AG-3 'and reverse 5'-AAG GAG GTG ATC CAG CCG CA-3 '(Ulrike, 1989), in a 25 µL reaction with 1X of 10X buffer, 2.5 µM MgCl2, 250 µM of each DNTP, 2.5 µM forward primer, 2.5 µM reverse primer 1.25 DNA polymerase units (AmpliTaq Applied) and 100 ng of DNA bacterial. The amplification was performed in a GeneAmp thermocycler 2700 (Applied Biosystems) with the following conditions: 95ºC 5 minutes, followed by 25 cycles of 94 ° C 30 seconds, 65.5 ° C 30 seconds and 72ºC 30 seconds, ending with 7 minutes at 72ºC.

Visualización de los gelesDisplay of the gels

El producto de PCR se resolvió en gel de agarosa al 1% (p/v) en tampón Tris-Acetato-EDTA (TAE 1%) con bromuro de etidio (0,5 mg/mL) y se visualizaron en un analizador de imagen GelDoc2000TM 170-8126 (Biorad, CA, EE.UU).The PCR product was resolved on agarose gel. 1% (w / v) in buffer Tris-Acetate-EDTA (TAE 1%) with ethidium bromide (0.5 mg / mL) and were visualized on an analyzer GelDoc2000TM 170-8126 image (Biorad, CA, USA).

Secuenciación de ADNDNA sequencing

Una vez comprobada la amplificación, el producto de PCR, se purificó con el kit UltraClean™ PCR Clean-up DNA purification (MoBio, CA, EE.UU.), se secuenció UNIDAD DE GENÓMICA PARQUE CIENTÍFICO DE MADRID-U.C.M. en un secuenciador ABI PRIMS® 377 ADN Sequencer (Applied Biosystems, CA, USA).Once the amplification is verified, the product PCR, was purified with the UltraClean ™ PCR kit Clean-up DNA purification (MoBio, CA, USA), is Sequence of GENOMICS SCIENTIFIC PARK OF MADRID-U.C.M. in an ABI PRIMS® 377 DNA sequencer Sequencer (Applied Biosystems, CA, USA).

Análisis informático de la secuenciaComputer sequence analysis

Las secuencias se alinearon con el programa Bioedit Sequence Aligment editor 5.0.3. ®, se revisaron manualmente se corrigieron y se analizaron por BLASTN 2.2.6.(Altschul et al., 1997) en el GeneBank EMBL y DDBJ (página Web del NCBI BLASTR: http://www.ncbi.nlm.nih.gov/), resultando la mayor homología: Pseudomonas sp. DK4 EU158318, y quedando depositada la secuencia en el GeneBank con el número de acceso AY748893.The sequences were aligned with the Bioedit Sequence Aligment editor 5.0.3 program. ®, were manually reviewed and corrected and analyzed by BLASTN 2.2.6 (Altschul et al. , 1997) on the GeneBank EMBL and DDBJ (NCBI BLASTR website: http://www.ncbi.nlm.nih.gov /), resulting in the highest homology: Pseudomonas sp. DK4 EU158318, and the sequence being deposited in the GeneBank with the access number AY748893.

Pseudomonas fluorescens como elicitor del metabolismo secundario de compuestos fenólicos Pseudomonas fluorescens as elicitor of the secondary metabolism of phenolic compounds

1º. Experimento de elicitación en plantas de Hypericum perforatum aplicando la bacteria en la raíz.- Se inoculó una suspensión bacteriana de la cepa N21.4 en la raíz de plántulas de Hypericum perforatum dos semanas después de la germinación y posteriormente, se inocularon cada dos semanas, durante 12 semanas. Se observó una inducción de la síntesis de los principios activos hipericina y pseudohipericina, logrando un incremento en la concentración de estos principios activos.1st. Experiment of elicitation in Hypericum perforatum plants by applying the bacteria in the root.- A bacterial suspension of strain N21.4 was inoculated into the root of Hypericum perforatum seedlings two weeks after germination and subsequently, inoculated every two weeks, for 12 weeks An induction of the synthesis of the active substances hypericin and pseudohypericine was observed, achieving an increase in the concentration of these active ingredients.

2º. Experimento de elicitación en plántulas de soja (Glycine max var. Osumi) inoculando la bacteria a nivel radical. Se pregerminaron semillas de soja y se transplantaron a macetas rellenas con vermiculita estéril. Se inoculó la cepa y a los 8 días de la inoculación se cosecharon las plántulas y se determinó la concentración de isoflavonas totales, analizando pormenorizadamente las distintas familias de isoflavonas presentes en la soja, así como las distintas especies químicas y su distribución en la planta. Se encontró que esta cepa era capaz de incrementar el contenido en isoflavonas totales, concretamente aumentando la concentración de isoflavonas pertenecientes a las de las familias de la Daizeina y de la Genisteina, especialmente en las hojas y cotiledones. Además, aumentaban de forma notable las formas glicosiladas y los malonilderivados, que son las formas de transporte, lo que indica que hay síntesis de novo y que hay transporte hacia los órganos en desarrollo.2nd. Elicitation experiment in soybean seedlings ( Glycine max var. Osumi) inoculating the bacteria at a radical level. Soybeans were pre-germinated and transplanted into pots filled with sterile vermiculite. The strain was inoculated and after 8 days of inoculation the seedlings were harvested and the concentration of total isoflavones was determined, analyzing in detail the different families of isoflavones present in soybeans, as well as the different chemical species and their distribution in the plant. It was found that this strain was capable of increasing the total isoflavone content, specifically increasing the concentration of isoflavones belonging to the families of Daizein and Genistein, especially in leaves and cotyledons. In addition, glycosylated and malon-constructed forms, which are the forms of transport, increased markedly, indicating that there is de novo synthesis and that there is transport to developing organs.

3º. Experimento de elicitación en semillas de soja (Glycine max var. Osumi) aplicando la bacteria y polisacáridos de esta bacteria. Este experimento se realizó haciendo un corte en la zona del embrión de semillas de soja y aplicando la bacteria y sus dos fracciones polisacarídicas solubles en agua (mayor de 10 kd y menor de 10 kd), en una concentración de 0.01 mg/mL. Se determinó la concentración de isoflavonas a los 4 días del tratamiento. Si bien en ese corto periodo de tiempo no se incrementaba el contenido total en isoflavonas, sí se alteraba la concentración relativa de éstas, es decir, aumentaban las formas agliconas (formas activas tanto para la defensa de la planta como para la salud humana) en detrimento de las formas glicosiladas y malonilderivados - Los resultados fueron semejantes tanto en el caso de inoculación de la bacteria como cuando se aplican las fracciones polisacaridicas sobre la familia de la daizenia; sin embargo, sólo la fracción de mayor peso molecular era capaz de aumentar significativamente el contenido en isoflavonas de la familia de la genisteina.3rd. Elicitation experiment in soybeans ( Glycine max var. Osumi) applying the bacteria and polysaccharides of this bacterium. This experiment was performed by cutting the area of the soybean embryo and applying the bacteria and its two water-soluble polysaccharide fractions (greater than 10 kd and less than 10 kd), at a concentration of 0.01 mg / mL. The concentration of isoflavones was determined 4 days after treatment. Although in that short period of time the total isoflavone content was not increased, the relative concentration of these was altered, that is, the aglycone forms (active forms both for the defense of the plant and for human health) were increased. detriment of glycosylated and malontructivated forms - The results were similar both in the case of inoculation of the bacterium and when polysaccharide fractions are applied to the daizenia family; however, only the fraction with the highest molecular weight was able to significantly increase the isoflavone content of the genistein family.

4º. Experimento de elicitación en cultivos celulares de soja (Glycine max var. Osumi) aplicando polisacáridos de superficie de esta bacteria. Este experimento se realizó aplicando las dos fracciones polisacaridicas solubles en agua (mayor de 10 kd y menor de l0 kd), en una concentración de 0.01 mg/mL en el medio de cultivo de las células (callos celulares). Se determinó la concentración de isoflavonas a los 15 días del tratamiento. Se detectó un incremento en el contenido total en isoflavonas, debidas fundamentalmente al incremento en la familia de la Daidzeina aumentando especialmente las formas glicosiladas y malonilderivados en detrimento de las formas agliconas; sólo la fracción de mayor peso molecular era capaz de aumentar el contenido en isoflavonas de la familia de la genisteina.4th. Elicitation experiment in soybean cell cultures ( Glycine max var. Osumi) applying surface polysaccharides of this bacterium. This experiment was performed by applying the two water-soluble polysaccharide fractions (greater than 10 kd and less than 10 kd), at a concentration of 0.01 mg / mL in the cell culture medium (cell calluses). Isoflavone concentration was determined 15 days after treatment. An increase in the total isoflavone content was detected, mainly due to the increase in the Daidzein family, especially increasing glycosylated and malonstituted forms to the detriment of aglycone forms; Only the fraction with the highest molecular weight was able to increase the isoflavone content of the genistein family.

Aplicación industrialIndustrial application

Dadas las propiedades arriba apuntadas de Pseudomonas fluorescens N21.4 como estimulador del metabolismo secundario de compuestos fenólicos, esta cepa bacteriana tiene una aplicación específica en la industria agroalimentaria, química y farmacéutica, al poder ser utilizada formando parte de cualquier preparado (de forma individual o en combinación con otros microorganismos) y haciéndolas entrar en contacto (a la cepa o cualquier parte de ella) con la semilla, el sistema radical o aéreo de las plantas por cualquier medio disponible, en cualquier especie vegetal, o en cualquier forma de cultivo in vitro, para incrementar la concentración de metabolitos secundarios de naturaleza fenólica con interés farmacológico y/o nutricional, o para fortalecer a las plantas frente a los agentes patógenos externos.Given the above-mentioned properties of Pseudomonas fluorescens N21.4 as a stimulator of the secondary metabolism of phenolic compounds, this bacterial strain has a specific application in the agri-food, chemical and pharmaceutical industry, being able to be used as part of any preparation (individually or in combination with other microorganisms) and bringing them into contact (to the strain or any part of it) with the seed, the radical or aerial system of the plants by any means available, in any plant species, or in any form of cultivation in vitro , to increase the concentration of secondary metabolites of phenolic nature with pharmacological and / or nutritional interest, or to strengthen plants against external pathogens.

Claims (11)

1. Pseudomonas fluorescens N21.4 (CECT 7620), microorganismo del grupo de las bacterias Gram género Pseudomonas, caracterizado por su capacidad estimulante del metabolismo secundario de compuestos fenólicos en especies vegetales, actuando de forma directa en plantas de interés farmacológico y nutricional, y protegiéndolas frente al ataque de agentes biológicos patógenos, resultando también de interés fitosanitario.1. Pseudomonas fluorescens N21.4 (CECT 7620), a microorganism of the Gram genus Pseudomonas group of bacteria, characterized by its stimulating ability of the secondary metabolism of phenolic compounds in plant species, acting directly on plants of pharmacological and nutritional interest, and protecting them against the attack of pathogenic biological agents, also being of phytosanitary interest. 2. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquier molécula derivada de ella, según reivindicación 1, para su aplicación en cualquier tipo de cultivo agrario o forestal, a fin de incrementar la producción de compuestos fenólicos del metabolismo secundario de interés farmacológico, nutricional y/o fitosanitario.2. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any molecule derived therefrom, according to claim 1, for application in any type of agricultural or forestry crop, in order to increase the production of phenolic compounds of the secondary metabolism of Pharmacological, nutritional and / or phytosanitary interest. 3. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquier molécula derivada de ella, según reivindicación 2, para su aplicación en cualquier especie de plantas de la familia Leguminosae con el objeto de incrementar su capacidad de producción de compuestos fenólicos de interés farmacológico, nutricional y/o fitosanitario.3. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any molecule derived therefrom, according to claim 2, for application in any species of plants of the Leguminosae family in order to increase their production capacity of phenolic compounds of Pharmacological, nutritional and / or phytosanitary interest. 4. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquier molécula derivada de ella, según reivindicación 3, para su aplicación en plántulas de soja (Glycine max. Osumi), con el objeto de incrementar su capacidad de producción de isoflavonas.4. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any molecule derived therefrom, according to claim 3, for application in soybean seedlings ( Glycine max. Osumi), in order to increase its isoflavone production capacity . 5. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquier molécula derivada de ella, según reivindicación 3, para su aplicación en semillas de plantas de soja (Glycine max. Osumi), con el objeto de modificar el perfil de isoflavonas, incrementando la concentración de agliconas.5. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any molecule derived from it, according to claim 3, for application in soybean plant seeds ( Glycine max. Osumi), in order to modify the isoflavone profile , increasing the concentration of aglicones. 6. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquier molécula derivada de ella, según reivindicación 2, para su aplicación en cualquier especie vegetal de las que constituyen los frutos rojos o frutos del bosque, como (fresa, frambuesa, mora, arándano, o mirtillo, con el objeto de incrementar su contenido en compuestos fenólicos de interés farmacológico, nutricional y/o fitosanitario.6. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any molecule derived from it, according to claim 2, for application in any plant species of which constitute red fruits or berries, such as (strawberry, raspberry, blackberry, cranberry, or mirtillo, in order to increase its content in phenolic compounds of pharmacological, nutritional and / or phytosanitary interest. 7. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquier molécula derivada de ella, según reivindicación 6, para su aplicación en mora (Rubus fruticosus), con el objeto de incrementar el contenido en antocianos y taninos.7. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any molecule derived therefrom, according to claim 6, for application in blackberry ( Rubus fruticosus ), in order to increase the content of anthocyanins and tannins. 8. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquiera de sus partes, según reivindicación 2, para su aplicación en cualquier especie de plantas de la familia Hypericaceae, con el objeto de incrementar el contenido de compuestos fenólicos de interés farmacológico.8. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any of its parts, according to claim 2, for application in any species of plants of the Hypericaceae family, in order to increase the content of phenolic compounds of pharmacological interest . 9. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), según reivindicación 8, para su aplicación en Hypericum perforatum, con el objeto de incrementar el contenido en hipericina y pseudohipericina.9. Use of Pseudomonas fluorescens N21.4 (CECT 7620), according to claim 8, for application in Hypericum perforatum , in order to increase the content of hypericin and pseudohypericin. 10. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquier molécula derivada de ella, según reivindicaciones 1 a 9, bien la cepa individual o en combinación con otros organismos, formando parte de cualquier preparado, ya sea individualmente o en combinación con otros organismos, y por cualquier medio disponible que ponga la bacteria en contacto con la semilla, el sistema radical o aéreo de las plantas.10. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any molecule derived from it, according to claims 1 to 9, either the individual strain or in combination with other organisms, forming part of any preparation, either individually or in combination with other organisms, and by any available means that puts the bacteria in contact with the seed, the radical or aerial system of the plants. 11. Uso de Pseudomonas fluorescens N21.4 (CECT 7620), o cualquier molécula derivada de ella, según reivindicaciones 1 a 9, bien la cepa individual o en combinación con otros organismos, o formando parte de cualquier preparado, ya sea individualmente o en combinación con otros organismos, y por cualquier medio disponible que ponga la bacteria en contacto con células procedentes de cualquier forma de cultivo in vitro.11. Use of Pseudomonas fluorescens N21.4 (CECT 7620), or any molecule derived therefrom, according to claims 1 to 9, either the individual strain or in combination with other organisms, or as part of any preparation, either individually or in combination with other organisms, and by any available means that puts the bacteria in contact with cells from any form of in vitro culture.
ES200902176A 2009-12-03 2009-12-03 PSEUDOMONAS FLUORESCENS N. 21.4 STIMULANT OF THE SECONDARY METABOLISM OF PHENOLIC COMPOUNDS. Expired - Fee Related ES2336758B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200902176A ES2336758B1 (en) 2009-12-03 2009-12-03 PSEUDOMONAS FLUORESCENS N. 21.4 STIMULANT OF THE SECONDARY METABOLISM OF PHENOLIC COMPOUNDS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200902176A ES2336758B1 (en) 2009-12-03 2009-12-03 PSEUDOMONAS FLUORESCENS N. 21.4 STIMULANT OF THE SECONDARY METABOLISM OF PHENOLIC COMPOUNDS.

Publications (2)

Publication Number Publication Date
ES2336758A1 ES2336758A1 (en) 2010-04-15
ES2336758B1 true ES2336758B1 (en) 2011-04-06

Family

ID=42060841

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200902176A Expired - Fee Related ES2336758B1 (en) 2009-12-03 2009-12-03 PSEUDOMONAS FLUORESCENS N. 21.4 STIMULANT OF THE SECONDARY METABOLISM OF PHENOLIC COMPOUNDS.

Country Status (1)

Country Link
ES (1) ES2336758B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018234599A1 (en) 2017-06-21 2018-12-27 Fundacion Universitaria San Pablo Bacillus amyloliquefaciens qv15 stimulant for the secondary metabolism of phenolic compounds and the inhibitory capacity of raspberry and strawberry extracts for enzymes related to metabolic syndrome

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2902976B2 (en) * 2021-09-21 2022-09-29 Biobab R&D S L Pseudomonas atacamensis CECT 30419 enhancer of plant production and stimulant of the secondary metabolism of plants.

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BASHA S. A., SARMA B. K., SINGH D. P., ANNAPURNA K., SINGH U. P. "{}Differential mehtods of inoculation of plant growth-promoting rhizobacteria induce synthesis of phenylalanine ammonia-lyase and phenolic compounds differentially in chickpea."{} Folia Microbiology (2006) Vol. 51, páginas 463-468. Páginas 463, 465 y 467. *
DOMENECH J., RAMOS S. B., PROBANZA A., LUCAS G. J. A., GUTIERREZ M. F. J. "{}Elicitation of systemic resistance and growth promotion of Arabidopsis Thaliana by PGPRs from Nicotiana glauca: a study of the putative induction pathway."{} Plant Soil (2007) Vol. 290 páginas 43-50. Páginas 44-46 y figuras 2 y 3. *
RAMOS SOLANO B., BARRIUSO MAICAS J., PEREYRA DE LA IGLESIA M.T., DOMENECH J., GUTIÉRREZ MAÑERO F.J. "{}Systemic disease protection elicited by plant growth promoting rhizobacteria strains: Relationship between metabolic responses, systemic disease protection, and biotic elicitors."{} Phytopathology (2008) Vol. 98, páginas 451-457. Páginas 451-452. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018234599A1 (en) 2017-06-21 2018-12-27 Fundacion Universitaria San Pablo Bacillus amyloliquefaciens qv15 stimulant for the secondary metabolism of phenolic compounds and the inhibitory capacity of raspberry and strawberry extracts for enzymes related to metabolic syndrome

Also Published As

Publication number Publication date
ES2336758A1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
Kumari et al. Plant growth promoting rhizobacteria and their biopriming for growth promotion in mung bean (Vigna radiata (L.) R. Wilczek)
Jie et al. Artificial inoculation of banana tissue culture plantlets with indigenous endophytes originally derived from native banana plants
Sharma et al. Multi-trait plant growth promoting bacteria from tomato rhizosphere and evaluation of their potential as bioinoculants
ES2336758B1 (en) PSEUDOMONAS FLUORESCENS N. 21.4 STIMULANT OF THE SECONDARY METABOLISM OF PHENOLIC COMPOUNDS.
Eissenberger et al. Plant variety and soil type influence Escherichia coli O104: H4 strain C227/11ϕcu adherence to and internalization into the roots of lettuce plants
Kannahi et al. Efficiency of plant growth promoting rhizobacteria for the enhancement of Vigna mungo growth
Sharma et al. Novel synergism of Cedecea lapagei KU14 and Bacillus subtilis KU21 for sustainable productivity of Rosmarinus officinalis in Northwest Himalayas
Monteiro et al. Comparison of the bacterial community and characterization of plant growth-promoting rhizobacteria from different genotypes of Chrysopogon zizanioides (L.) Roberty (vetiver) rhizospheres
Guleria et al. Population and functional diversity of phosphate solubilizing bacteria from apricot (Prunus armeniaca) of mid and high regions of Himachal Pradesh
ES2269004B2 (en) USE OF ARTHROBACTER OXIDANS BB1 AS A PROTECTOR AGAINST SALINE STRESS.
ES2694593B2 (en) Bacillus amyloliquefaciens QV15 stimulates the secondary metabolism of phenolic compounds and the inhibitory capacity of the extracts of frambruesa and strawberry on the enzymes related to the metabolic syndrome
Botelho et al. Plant growth promoting bacteria from garlic sowed at Curitibanos micro-region-Santa Catarina-Brazil
ES2902976B2 (en) Pseudomonas atacamensis CECT 30419 enhancer of plant production and stimulant of the secondary metabolism of plants.
CN117535171B (en) Salt stress induced soybean recruitment sword fungus Ensifer sp.GMS14 and application thereof
Lima et al. Root growth in tomato seedlings in response to bacterial inoculation Serratia sp.
Ikeda et al. Bio prospecting plant growth-promoting bacteria isolated from maize (Zea mays L.) roots
Karnwal Effect of halotolerant plant growth-promoting rhizobacteria from Bougainvillea glabra on wheat and maize seedlings under NaCl stress
Khambalkar et al. Isolation and characterization of nitrogen fixing Burkholderia Sp.
Lakoro et al. Endophytic Bacteria Producing Antimicrobial Compounds of Musa balbisiana Colla
Sankaralingam et al. Effect of Phosphate solublizing bacteria on growth and development of Sesbania grandiflora and Moringa oleifera
Abboodi et al. Isolation of multi-trait plant growth-promoting Serratia marcescens and evaluation of growth-promoting effects on wheat plant under salinity stress
Chauhan et al. Endophytic Bacteria Showing Antioxidant Property from Periwinkle [Catharanthus roseus (L.) G. Don]
Raja et al. Tracing Transmission of Salmonella enterica subsp. enterica in Tomato Fruits
Lakhdar et al. Plant growth-promoting endophytic bacteria isolated from Launaea arborescens (characterization and molecular identification)
Thanh et al. Characterization of phosphate and potassium solubilization, and antifungal activity of bacteria isolated from rhizosphere of Allium ascalonicum (L.) grown in Ninh Hai district, Ninh Thuan province, Vietnam

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20100415

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2336758

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20110406

GC2A Exploitation certificate registered application with search report

Effective date: 20140602

FD2A Announcement of lapse in spain

Effective date: 20240327